JOANA LUKASIK: Open Payments
NPI 1265172191 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $147 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $167 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: Wegovy, BREZTRI, CAPLYTA, GVOKE HYPOPEN, FARXIGA, SHINGRIX, OTEZLA, NEXLETOL.
Industry payments across NC — which companies pay providers there.
